Summary & Overview
HCPCS P9033: Leukocyte-Reduced, Irradiated Platelet Unit
HCPCS Level II code P9033 denotes a single unit of platelets that have been leukocyte reduced and irradiated. This code captures a specialized blood product used to reduce alloimmunization, febrile nonhemolytic transfusion reactions, and the risk of transfusion-associated graft-versus-host disease in immunocompromised patients. Nationally, billing for modified blood components is a routine but clinically significant area because it intersects transfusion safety protocols, supply logistics, and payer coverage rules.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for use of P9033, payer coverage considerations, common billing modifiers, and how this code is recorded on service lines. The publication outlines typical sites of service where these units are administered and clarifies what information is available versus not provided in the input.
The report is intended for hospital billing managers, transfusion services, and healthcare policy analysts seeking a concise reference on coding and clinical context for leukocyte reduced, irradiated platelet units. Data not available in the input is identified explicitly where applicable.
Billing Code Overview
HCPCS Level II code P9033 represents platelets that have been leukocyte reduced and irradiated, billed per unit. The service consists of preparation and provision of a platelet unit that has undergone leukoreduction to remove white blood cells and irradiation to reduce risk of transfusion-associated graft-versus-host disease.
Service type: Blood product transfusion / blood component supply
Typical site of service: Hospital inpatient or outpatient transfusion center, ambulatory infusion center, or blood bank facility
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric inpatient or outpatient requiring transfusion of platelet concentrates that have been leukocyte-reduced and irradiated to prevent alloimmunization and transfusion-associated graft-versus-host disease. Common scenarios include patients with hematologic malignancies (for example acute leukemia undergoing chemotherapy), stem cell transplant recipients, or individuals with severe thrombocytopenia due to aplastic anemia or myelodysplastic syndromes. The clinical workflow: the ordering clinician documents the indication and transfusion threshold in the medical record; blood bank issues a unit labeled as Platelets, leukocytes reduced, irradiated (HCPCS P9033), performs required infectious disease testing and compatibility checks, and records irradiation and leukoreduction processing in the transfusion record; bedside nursing verifies patient identity, reviews pretransfusion vitals and consents, and administers the unit per facility transfusion protocol with post-transfusion monitoring and documentation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no modifier applies to the service |